PARIS (Reuters) - The International Cycling Union (UCI) is reviewing its procedure over therapeutic use exemptions (TUEs) after granting Tour de France winner Chris Froome the right to use a steroid-based drug in April.
"Working closely with the World Anti-Doping Agency and its director-general David Howman, the UCI has been reviewing all of its anti-doping rules and procedures including those regarding therapeutic use exemptions," the UCI said in a statement on Monday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
